| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3316321 | Pancreatology | 2016 | 33 Pages |
Abstract
With a threshold value of 50,000 US$ per QALY this screening program appears to constitute a cost-effective intervention although screening of HP patients appears to be less cost-effective than FPC patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Maiken Thyregod Joergensen, Anne-Marie Gerdes, Jan Sorensen, Ove Schaffalitzky de Muckadell, Michael Bau Mortensen,